Researchers revive an abandoned depression drug target using structurally novel NK1 receptor inhibitors

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...

What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

JPM26: Eli Lilly’s obesity drugs target commercial and governmental access

Eli Lilly has further expanded its weight-loss initiatives with novel therapies such as orforglipron, an oral GLP-1 receptor ...
News-Medical.Net

New chemistry revives neurokinin-1 receptor as depression treatment target

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
NC Biotech

RedHill GI-soothing pill targets weight-loss, cancer drug side effects

RedHill Biopharma says it’s getting good results in clinical trials using ondansetron pills to help alleviate side effects such as nausea, vomiting and diarrhea among people using the blockbuster ...
Hoodline

San Diego’s Billion-Cell Power Play: Illumina Bets Big On Drug Discovery

Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
BioTechniques

AI pinpoints new drug target for treating monkeypox virus

Scientists have used AlphaFold 3 to identify a potential new drug target to treat monkeypox virus. With the help of artificial intelligence (AI), an international team of researchers has made the ...